Similar articles

• Chronic hepatitis C virus infection.

  Flamm SL. Flamm SL. JAMA. 2003 May 14;289(18):2413-7. doi: 10.1001/jama.289.18.2413. JAMA. 2003. PMID: 12746366 Review. No abstract available.
• Pegylated interferon treatment in HCV genotype 2 and 3 patients refractory to conventional interferon.

  Aziz S. Aziz S. J Coll Physicians Surg Pak. 2012 Oct;22(10):615-6. doi: 10.2012/JCPSP.615616. J Coll Physicians Surg Pak. 2012. PMID: 23058141 No abstract available.
• [Therapy of chronic Hepatitis C in 2008].

  Niederau C, Kaden T. Niederau C, et al. MMW Fortschr Med. 2008 Mar 27;150(13):31-4. doi: 10.1007/BF03365407. MMW Fortschr Med. 2008. PMID: 18522354 Review. German. No abstract available.
• Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents.

  Berzsenyi MD, Roberts SK. Berzsenyi MD, et al. J Gastroenterol Hepatol. 2010 Apr;25(4):655-6. doi: 10.1111/j.1440-1746.2010.06283.x. J Gastroenterol Hepatol. 2010. PMID: 20492322 No abstract available.
• Peginterferon and ribavirin for chronic hepatitis C.

  Hoofnagle JH, Seeff LB. Hoofnagle JH, et al. N Engl J Med. 2006 Dec 7;355(23):2444-51. doi: 10.1056/NEJMct061675. N Engl J Med. 2006. PMID: 17151366 Review. No abstract available.